Marcus R, Avigdor A, Greenbaum U, Brown S, Fried S, Golan-Accav N, Shem-Tov N, Yerushalmi R, Danylesko I, Jacoby E, Nagler A, Shimoni A, Itzhaki O, Esensten J, Valid OB, Ballweg A, Deschênes-Simard X, Luttwak E, Shah G, Scordo M, Dahi P, Perales M-A, Zuckerman T, Devlin SM, Yehudai-Ofir D, Khatib H, Shibly N, Shouval R, Beyar-Katz O. Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma: a multicenter propensity scorematched analysis. haematol [Internet]. 2026Jun.1 [cited 2026Jun.6];111(6):2023-31. Available from: https://haematologica.org/article/view/13066